Improved survival after radiotherapy for brain metastases in patients with HER2 positive breast tumors.

被引：0
|
作者：
Maur, M [1 ]
Frassoldati, A [1 ]
Piacentini, F [1 ]
Ramundo, D [1 ]
Sabbatini, R [1 ]
Giovannelli, S [1 ]
Ficarra, G [1 ]
Bertolini, F [1 ]
Falchi, AM [1 ]
Conte, PF [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Modena, Italy
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2005年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [21] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Horimoto, Yoshiya
    Ishizuka, Yumiko
    Ueki, Yuko
    Higuchi, Toru
    Arakawa, Atsushi
    Saito, Mitsue
    BMC CANCER, 2022, 22 (01)
  • [22] HER2 activity in solid tumors.
    Kujtan, Lara Ann
    Morris, Scott
    Subramanian, Janakiraman
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Extended trastuzumab therapy improves the survival of HER2-positive breast cancer patients following surgery and radiotherapy for brain metastases
    Okita, Yoshiko
    Narita, Yoshitaka
    Suzuki, Tsuyoshi
    Arita, Hideyuki
    Yonemori, Kan
    Kinoshita, Takayuki
    Fujiwara, Yasuhiro
    Tsuda, Hitoshi
    Komoike, Yoshifumi
    Nakagawa, Hidemitsu
    Tamaki, Yasuhiro
    Tomita, Yasuhiko
    Shibui, Soichiro
    Maruno, Motohiko
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (06) : 995 - 1001
  • [24] Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
    Yoshiya Horimoto
    Yumiko Ishizuka
    Yuko Ueki
    Toru Higuchi
    Atsushi Arakawa
    Mitsue Saito
    BMC Cancer, 22
  • [25] Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases
    Khatri, Vaseem M.
    Mills, Matthew N.
    Oliver, Daniel E.
    Yu, Hsiang-Hsuan Michael
    Vogelbaum, Michael A.
    Forsyth, Peter A.
    Soliman, Hatem H.
    Han, Hyo S.
    Ahmed, Kamran A.
    JOURNAL OF NEURO-ONCOLOGY, 2023, 164 (1) : 191 - 197
  • [26] Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases
    Vaseem M. Khatri
    Matthew N. Mills
    Daniel E. Oliver
    Hsiang-Hsuan Michael Yu
    Michael A. Vogelbaum
    Peter A. Forsyth
    Hatem H. Soliman
    Hyo S. Han
    Kamran A. Ahmed
    Journal of Neuro-Oncology, 2023, 164 : 191 - 197
  • [27] Risk of brain metastases in HER2/neu-positive breast cancer.
    Altaha, R
    Crowell, E
    Ducatman, B
    Higa, G
    Abrahan, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 47S - 47S
  • [28] Luminal B breast tumors are not HER2 positive
    Rohit Bhargava
    David J Dabbs
    Breast Cancer Research, 10
  • [29] Luminal B breast tumors are not HER2 positive
    Bhargava, Rohit
    Dabbs, David J.
    BREAST CANCER RESEARCH, 2008, 10 (05)
  • [30] Extended survival in women with brain Metastases from HER2 overexpressing breast cancer
    Church, David N.
    Modgil, Ramayana
    Guglani, Sam
    Bahl, Amit
    Hopkins, Kirsten
    Braybrooke, Jeremy P.
    Blair, Peter
    Price, Chris G. A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (03): : 250 - 254
12345